title: "Should all eligible patients with multiple myeloma receive autologous stem-cell transplant as part of initial treatment?".
authors.forename: Philippe
authors.initials: P
authors.lastname: Moreau
authors.forename: S Vincent
authors.initials: SV
authors.lastname: Rajkumar
mesh_terms: D019317:Evidence-Based Medicine / Q000379:methods; D006801:Humans; D009101:Multiple Myeloma / Q000175:diagnosis / Q000628:therapy*; D020360:Neoadjuvant Therapy / Q000379:methods*; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D033581:Stem Cell Transplantation / Q000379:methods / Q000706:statistics & numerical data*; D013997:Time Factors; D014182:Transplantation, Autologous